Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Male factor infertility and risk of death: a nationwide record-linkage study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Risk of hospitalization for early onset of cardiovascular disease among infertile women: a register-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Xeno-Free Propagation of Spermatogonial Stem Cells from Infant Boys

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Chromosome errors in human eggs shape natural fertility over reproductive life span

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

STUDY QUESTION: What are the results of transplanting cryopreserved ovarian tissue?

SUMMARY ANSWER: The transplanted ovarian tissue can last up to 10 years, with no relapses following the 53 transplantations, and the chance of a successful pregnancy is currently around one in three for those with a pregnancy-wish.

WHAT IS KNOWN ALREADY: Cryopreservation of ovarian tissue is now gaining ground as a valid method for fertility preservation. More than 36 children worldwide have now been born following this procedure.

STUDY DESIGN, SIZE, DURATION: This is a retrospective cohort study of 41 women who had thawed ovarian tissue transplanted 53 times over a period of 10 years, including 1 patient who was lost to follow-up.

PARTICIPANTS/MATERIALS, SETTING, METHODS: The 41 Danish women, who had in total 53 transplantations, were followed for ovarian function and fertility outcome. Safety was assessed by monitoring relapse in cancer survivors.

MAIN RESULTS, AND THE ROLE OF CHANCE: Among 32 women with a pregnancy-wish, 10 (31%) had a child/children (14 children in total); this included 1 woman with a third trimester on-going pregnancy. In addition, two legal abortions and one second trimester miscarriage occurred. A total of 24 clinical pregnancies were established in the 32 women with a pregnancy-wish. The tissue remained functional for close to 10 years in some cases and lasted only a short period in others. Three relapses occurred but were unlikely to be due to the transplanted tissue.

LIMITATIONS, REASONS FOR CAUTION: Self-report through questionnaires with only in-one hospital formalised follow-up of transplanted patients could result in unreported miscarriages. The longevity of the tissue may vary by few months compared with those reported because some patients simply could not remember the date when the tissue became non-functional.

WIDER IMPLICATIONS OF THE FINDINGS: Cryopreservation of ovarian tissue is likely to become integrated into the treatment of young women, with cancer, who run a risk of losing their fertility. The full functional lifespan of grafts is still being evaluated, because many of the transplanted women have continued to maintain ovarian activity. Some of our first cases have had tissue functioning for ∼10 years.

STUDY FUNDING/COMPETING INTERESTS: The Child Cancer Foundation in Denmark (2012-26) and the EU interregional project ReproHigh are thanked for having funded this study. They had no role in the study design, collection and analysis of data, data interpretation or writing of the report. The authors have no conflict of interest to disclose.

Original languageEnglish
JournalHuman reproduction (Oxford, England)
Volume30
Issue number12
Pages (from-to)2838-45
Number of pages8
ISSN0268-1161
DOIs
Publication statusPublished - Dec 2015

ID: 46045679